Trial on HBM-Based Education for ROP Screening in Premature Infants' Parents
A clinical trial is assessing the effectiveness of HBM-based educational interventions on ROP screening knowledge among parents.
Phase III
Ophthalmology / Retinopathy of Prematurity
Status
Active
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Why it matters
This trial explores innovative educational strategies aimed at improving parental knowledge of Retinopathy of Prematurity (ROP) screening, which could significantly influence clinical practices in pediatric ophthalmology. Successful outcomes may lead to widespread adoption of new educational interventions, reshaping the landscape of ROP management.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results from the follow-up questionnaires and any changes in screening practices post-intervention.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.